Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.

Antimicrobial Agents and Chemotherapy
Marc SeidlerFrank-Michael C Müller

Abstract

Aspergillus fumigatus is a leading cause of death in immunocompromised patients and a frequent colonizer of the respiratory tracts of asthma and cystic fibrosis (CF) patients. Biofilms enable bacteria and yeasts to persist in infections and can contribute to antimicrobial resistance. We investigated the ability of A. fumigatus to form biofilms on polystyrene (PS) and human bronchial epithelial (HBE) and CF bronchial epithelial (CFBE) cells. We developed a novel in vitro coculture model of A. fumigatus biofilm formation on HBE and CFBE cells. Biofilm formation was documented by dry weight, scanning electron microscopy (SEM), and confocal scanning laser microscopy (CSLM). The in vitro antifungal activities of seven antifungal drugs were tested by comparing planktonic and sessile A. fumigatus strains. A. fumigatus formed an extracellular matrix on PS and HBE and CFBE cells as evidenced by increased dry weight, SEM, and CSLM. These biofilms exhibited decreased antifungal drug susceptibility and were adherent to the epithelial cells, with fungi remaining viable throughout 3 days. These observations might have implications for treatment of A. fumigatus colonization in chronic lung diseases and for its potential impact on airway infla...Continue Reading

References

Apr 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W BaddleyP G Pappas
Aug 22, 2001·Trends in Microbiology·J P Latgé
Oct 31, 2002·Applied and Environmental Microbiology·Gordon RamageJosé L López-Ribot
Jul 17, 2004·Molecular Microbiology·Mary T KellyGeraldine Butler
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·D C GruenertR A Frizzell
Apr 12, 2005·Eukaryotic Cell·Gordon RamageJosé L López-Ribot
May 5, 2005·Microbiology·Bruce L GrangerJim E Cutler
May 6, 2006·American Journal of Respiratory and Critical Care Medicine·Timothy D StarnerPaul B McCray
Nov 15, 2006·International Journal of Antimicrobial Agents·Marc SeidlerFrank-Michael C Müller
Mar 21, 2007·Cellular Microbiology·Anne BeauvaisJean Paul Latgé
Jan 18, 2008·Journal of Clinical Microbiology·Andrew M BormanElizabeth M Johnson

❮ Previous
Next ❯

Citations

Apr 1, 2010·Applied Microbiology and Biotechnology·Norma N GamarraMarcel Gutiérrez-Correa
Dec 7, 2011·Journal of Industrial Microbiology & Biotechnology·Christopher T CornelisonSidney A Crow
Feb 22, 2012·Applied Biochemistry and Biotechnology·Marcel Gutiérrez-CorreaGretty K Villena
Oct 1, 2010·Journal of Bronchology & Interventional Pulmonology·Thomas A DillardAlbert S Chang
Jun 8, 2011·Microbiology and Molecular Biology Reviews : MMBR·Rebecca S ShapiroLeah E Cowen
Apr 21, 2012·International Journal of Microbiology·Gordon RamageCraig Williams
Dec 22, 2011·International Journal of Microbiology·Patrick VandeputteAlix T Coste
Sep 21, 2011·PLoS Pathogens·Nicole RobbinsLeah E Cowen
Aug 18, 2009·International Journal of Chronic Obstructive Pulmonary Disease·Florence AderSaad Nseir
Nov 12, 2010·Medical Mycology·Françoise SymoensJean-Philippe Bouchara
Jan 25, 2011·Medical Mycology·Frank-Michael C MüllerAnne Beauvais
Nov 12, 2010·Medical Mycology·Emmanuel Roilides, Maria Simitsopoulou
Jun 19, 2012·Future Microbiology·Mayra Cuéllar-CruzEstela Ruiz-Baca
Aug 22, 2013·Medical Mycology·Savneet Kaur, Shweta Singh
Jun 11, 2011·Current Fungal Infection Reports·Luis R Martinez, Bettina C Fries
Sep 16, 2015·Critical Reviews in Microbiology·Jessica C Song, David A Stevens
Oct 30, 2009·Critical Reviews in Microbiology·Gordon RamageJose Lopez-Ribot
Aug 11, 2010·Expert Review of Anti-infective Therapy·Frank-Michael C Müller, Marc Seidler
Feb 2, 2012·International Journal of Medical Microbiology : IJMM·Takahito ToyotomeKatsuhiko Kamei
Mar 30, 2010·Revista iberoamericana de micología·Bibiana ZapataAna Cecilia Mesa-Arango
Dec 4, 2015·Critical Care : the Official Journal of the Critical Care Forum·Claire DelsucFlorence Ader
Nov 6, 2009·Cellular Microbiology·Fabrice N GravelatDonald C Sheppard
Mar 31, 2015·BioMed Research International·Zhongqi FanHuimei Yu
Apr 17, 2015·BMC Microbiology·Adrián Ramírez GranilloAída Verónica Rodríguez Tovar
Jul 21, 2012·International Journal of Pharmaceutics·Mélanie FauvelGillian Barratt
Jun 23, 2009·Current Opinion in Microbiology·Christophe d'Enfert
Mar 15, 2014·The International Journal of Biochemistry & Cell Biology·Sanjay H Chotirmall, Noel G McElvaney
Jan 15, 2014·FEMS Microbiology Letters·Michael WinnCormac D Murphy
Nov 19, 2011·FEMS Microbiology Letters·Gordon RamageCraig Williams
May 27, 2014·Biofouling·C B Costa-OrlandiM J S Mendes-Giannini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.